Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 16Liver Neoplasms 7Pancreatic Neoplasms 4Cholangiocarcinoma 4Colorectal Neoplasms 3Thyroid Nodule 2Thyroid Diseases 2Neoplasm Metastasis 2Gallbladder Neoplasms 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Recurrence 1Papillary Thyroid Microcarcinoma 1Neoplasms, Glandular and Epithelial 1Neoplasms 1NSCLC 1Lung Neoplasms 1Hypertension, Portal 1Hyperaldosteronism 1Hepatitis B 1Hepatic Metastasis of Colorectal Cancer 1Head and Neck Neoplasms 1HCC 1Colorectal Cancer Liver Metastases 1Colonic Neoplasms 1Cholestasis 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Cyclophosphamide 17fludarabine 13Dexamethasone 12Cisplatin 12Rituximab 10Gemcitabine 9Paclitaxel 8Bendamustine Hydrochloride 8Lenalidomide 7Decitabine 7Cytarabine 7Carboplatin 7fludarabine phosphate 6N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6Etoposide 6Bortezomib 6Radiotherapy 5Injections 5Azacitidine 5camrelizumab 4apatinib 4Valproic Acid 4Thalidomide 4Procarbazine 4Oxaliplatin 4Drug Therapy 4Bevacizumab 4Antilymphocyte Serum 4venetoclax 3pomalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Recurrence × Radiofrequency Ablation × Clear all
NCT02187081 2017-03-28

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Southwest Hospital, China

Phase NA Unknown
380 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡